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Abstract
Background
There is little evidence on the accuracy of psychosis relapse prediction models. Our objec-
tive was to undertake a systematic review of relapse prediction models in psychosis.
Method
We conducted a literature search including studies that developed and/or validated psycho-
sis relapse prediction models, with or without external model validation. Models had to target
people with psychosis and predict relapse. The key databases searched were; Embase,
Medline, Medline In-Process Citations & Daily Update, PsychINFO, BIOSIS Citation Index,
CINAHL, and Science Citation Index, from inception to September 2016. Prediction model-
ling studies were assessed for risk of bias and applicability using the PROBAST tool.
Results
There were two eligible studies, which included 33,088 participants. One developed a
model using prodromal symptoms and illness-related variables, which explained 14% of
relapse variance but was at high risk of bias. The second developed a model using adminis-
trative data which was moderately discriminative (C = 0.631) and associated with relapse
(OR 1.11 95% CI 1.10, 1.12) and achieved moderately discriminative capacity when vali-
dated (C = 0.630). The risk of bias was low.
Conclusions
Due to a lack of high quality evidence it is not possible to make any specific recommenda-
tions about the predictors that should be included in a prognostic model for relapse. For
instance, it is unclear whether prodromal symptoms are useful for predicting relapse. The
use of routine data to develop prediction models may be a more promising approach,
although we could not empirically compare the two included studies.
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Introduction
People with psychosis have a high likelihood of relapse. The cumulative relapse rate five years
after initial recovery from psychosis is 82% and the second relapse rate is 78% [1]. Relapses
cause distress for patients and their carers [2]. It has also been suggested that repeated relapses
may have an adverse effect on the brain in terms of cognitive deterioration and less complete
recovery from subsequent relapses [3]. There is a reported association between relapse and
reduced social functioning, unemployment and social isolation [4] and evidence of a dose-
response effect with repeated relapses associated with greater cognitive decline and poorer
social functioning [3]. A recent projection of the total expenses of schizophrenia in the UK
reported costs of £1 billion per year [5], a significant proportion of which is inpatient treat-
ment [6], which may be a consequence of the most serious relapses. There is some evidence
from a recent systematic review to suggest that it is possible to intervene to reduce the likeli-
hood of relapse [7]. The most successful interventions reported were: patient psycho-educa-
tion, structured needs assessments, medication reconciliation and education, transition
managers and inpatient/outpatient provider communication. A tool to predict relapses in peo-
ple with psychosis could improve patient-outcomes, inform therapeutic decision-making,
allow the appropriate targeting of mental health service resources and therefore reduce treat-
ment costs. Evidence in favour of the accuracy of a tool to predict relapse in psychosis would
therefore be advantageous both for mental health care providers as well as service users and
carers. We are not aware of any systematic review of relapse prediction tools in psychosis. Our
aim was to systematically review the literature on existing models to predict relapse in people
with psychosis.
Method
This review followed the guidance published by the Centre for Reviews and Dissemination [8]
and the Cochrane Prognosis Methods Group [9]. We established a protocol for the review (S1
File) which pre-specified objectives, eligibility criteria and review methods. Reporting of the
review followed the PRISMA checklist (S1 Table).
Identification of studies
Seven electronic databases: Embase (OvidSP), Medline (OvidSP), Medline In-Process Cita-
tions & Daily Update (OvidSP), PsychINFO (OvidSP), BIOSIS Citation Index (Web of Sci-
ence), CINAHL (Cumulative Index to Nursing and Allied Health Literature–EBSCO), and
Science Citation Index (Web of Science) were searched from inception to September 2016 to
identify relevant studies of clinical prediction models of relapse in psychosis. Search methods
met best practice standards in systematic reviews [8, 10]. The search strategy (S2 File) com-
bined terms for psychosis and relapse with the Ingui filter for identifying prediction modelling
studies [11]. Searches were not limited by language, date or publication status.
An internet search using the Google search engine and screening reference lists of included
studies were used to identify any additional relevant unpublished studies (grey literature). The
authors of any grey literature were contacted to find out whether there were any unpublished
study results available.
Study selection
The inclusion criteria were defined based on the CHARMS (Checklist for critical Appraisal
and data extraction for systematic Reviews of prediction Modelling Studies) [12] guidelines.
We included studies that described prediction model development with or without external
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model validation studies. To qualify as a prediction modelling study a paper must have
reported a full multivariate model including regression coefficients and formally presented a
model that could be used to predict the probability of a psychotic relapse. Models had to target
people with a psychotic disorder (including schizophrenia), with single and multiple psychotic
episodes, and predict relapse or repeated relapse defined as admission or readmission to a psy-
chiatric inpatient unit or recurrence of psychotic symptoms over a threshold level (as defined
in the included study). There was no restriction on the time span of prediction or the intended
moment of using the model. Search results and full text articles were independently assessed
by two reviewers; disagreements were resolved through discussion or referral to a third
reviewer.
Data extraction
Data were extracted using standardised data extraction forms developed in Microsoft Access
2010. The forms were initially piloted on a small sample of papers and adapted as necessary.
To minimise bias and errors, data extraction was performed by one reviewer and checked by a
second. Data extracted for each study included; country of study, funding source, potential
conflicts of interest, type of study, participants, type of prediction model, duration of model
testing, types of outcome measure and types of predictors included in the model.
Quality assessment
Prediction modelling studies were assessed for risk of bias and applicability using the PRO-
BAST tool [13]. The assessment of risk of bias includes the domains of participant selection,
outcome, predictors, sample size and flow, and analysis. The first three domains are also
assessed for applicability to the systematic review question.
We used the PROBAST tool guidance to reach an overall judgement of risk of bias. This
stated that even if all domains were rated at low risk of bias a downgrade to a high risk should
be considered without validation of the model developed. A rating of low risk of bias should
only be considered if the development was based on a very large dataset and there was some
form of internal validation. The risk of bias assessment was conducted as part of the data
extraction process.
Analysis
Due to the small number of included studies and differences between studies meta-analysis
was not appropriate. A narrative synthesis was performed, including a summary of study char-
acteristics (study design, population size, geographical location, year, baseline population char-
acteristics, outcome definition and assessments) and findings reported as descriptive text and
tables. A detailed commentary on major methodological problems and biases was also
included.
Results
The search identified 9,838 hits of which two studies (total participants = 33,088) [14, 15] met
inclusion criteria (Fig 1). An additional six ongoing pilot studies from the grey literature search
were identified. After contact with the investigators listed in the grey literature it was found
that results from these studies were not available at the time of enquiring. These unpublished
studies were all testing methods to predict relapse using personal technologies such as smart
phone apps or wrist-worn activity monitors [16–21].
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The included studies were published in 2007 and 2015 and were set in Germany and Can-
ada. One [14] was restricted to people with a diagnosis of schizophrenia and used participants
from a trial of medication discontinuation and the second [15] included a broader diagnostic
Fig 1. PRISMA Flowchart of search and review strategy.
https://doi.org/10.1371/journal.pone.0183998.g001
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category of psychotic disorder. Mean age was 39 years. Both were cohort studies and had sam-
ples with slightly more women and included patients who had suffered multiple psychotic epi-
sodes with illness durations of five to seven years. One study reported model development
only and one [15] developed and validated a model using a split data sample method. Tables 1
and 2 provide an overview of the included studies.
Relapse was defined as an exacerbation of psychotic symptoms and a decrease in function-
ing [14] or as hospitalisation [15].
The number of candidate predictors used to develop the prediction models were 9 [14] and
22 [15]. The predictors were prodromal symptoms and global functioning [14]. and popula-
tion-based health administration data [15] (socio-demographic variables, prior health service
use, medical comorbidity, clinical and administrative information collected during index
admission and detailed rating scales and metrics calculated at discharge and admission).
Methods used to select candidate predictors for inclusion in the final model differed. One study
[14] used analyses based on 2x2 tables i.e. prodrome yes/no with relapse yes/no to derive measures
of sensitivity (the percentage of relapses correctly identified by the model–true positives) and speci-
ficity (the percentage of non-relapses correctly identified by the model–true negatives). Sensitivity
and specificity was calculated for various cut-offs using a Receiver Operating Characteristics
(ROC) analysis. Coefficients from logistic regression models were used to select variables from the
candidate predictors for the final prediction model. The other study[15] used log likelihood and
Chi square tests to make decisions about including predictors in the model. (see Table 2).
Multivariable logistic regression was used to fit the most predictive model in both studies.
Overall model fit was examined as well as discrimination using a C test in the study which vali-
dated its model [15]. To do this, the final logistic regression model was converted into a risk
index and a probability of relapse was created for each score of the risk index. A C statistic and
expected and observed probabilities of relapse were generated for both the derivation and vali-
dation samples to determine the calibration of the risk index.
One study [14] was judged at high risk of bias and the other [15] at low risk of bias. The
high risk of bias rating was due to concerns over the assessment of predictors and outcomes.
Other areas of concern were that not all the participants were included in the analysis and the
model developed was not validated. In contrast, the study rated at low risk of bias [15] had no
major areas of concern, largely because of the use of routine data sources. This study developed
and validated a prediction model using a split sample method, which is a less rigorous method
of model validation than using external data. An overall low risk of bias was considered appro-
priate for this study however, because model development was carried out on an extremely
large dataset and there was internal model validation. This rating is recommended under these
circumstances by the PROBAST tool [13]. See Table 3 for bias assessment results.
One study [15] had a short (i.e. 30 day) follow up period because its aim was to predict early
relapse. The other [14] had a longer follow up period (i.e. 2 years). The short follow up periods
of the included studies potentially reduced the number of relapses and included a higher pro-
portion of relapses occurring soon after recovery, which are likely to occur in those who are
more unwell or who are suffering from residual symptoms and who therefore may be more
likely to relapse. The findings therefore may not be generalizable to those who have recovered
from psychosis without residual symptoms.
There were no concerns regarding applicability for either of the included studies.
Study findings
The sensitivity of individual prodromal symptoms was below 40% and specificities ranged
from 70% to 95% [14]. The sensitivity for the overall prodromal score (OPS) at different cut
Models to predict relapse in psychosis: A systematic review
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offs ranged from 25% (specificity = 86%) to 72% (specificity 38%) [14]. The optimum cut-off
for the OPS score was3 (no prodromal state) vs4 (prodromal state) with a sensitivity of
39%, a specificity of 76%. The Area under the Curve (AUC) statistic was 0.59 The model which
included time between symptom report and relapse increased sensitivity to 80% if the time-
period was<21 days. Only depression, suspiciousness, motor-retardation, change in CGI
score were significantly associated with the outcome. The final prediction model (i.e. the OPS,
depression, suspiciousness, motor-retardation, change in CGI score, treatment group and a
single prodromal symptom “trouble sleeping”) only explained 14% of the variance in outcome.
The study [15] which used administrative data to form a risk of relapse prediction index
reported that a model containing data on socio-demographics, prior health service and clinical
and administrative variables was the most predictive model. The variables included in the final
model are shown in Table 2. The risk index (created from the final logistic regression model)
was associated with the outcome (OR 1.11 95% CI 1.10, 1.12) and the association appeared to
be linear. The model indicated acceptable calibration (C = 0.631 for the development dataset
and C = 0.630 for the validation dataset).
Discussion
Summary of results
We identified two studies that assessed the accuracy of models to predict relapse in people
with psychosis. One model was of limited predictive value [14] and the other [15] had moder-
ate discriminatory power.
One [14] of the studies was judged to be at high risk of bias, which may have resulted an
overestimate of the association. The second study [15] was judged at low risk of bias, in spite of
the fact that internal model validation was used, because it was conducted in a very large
dataset.
Table 2. Type of study and findings.
Study Model development Model
classification
Model performance Model
validation
Gaebel
et al 2007
[14]
Sensitivity, specificity, ORsa. Logistic regression also with
additional variables. ROCb analysis with different cut offs for
the overall prodromal score.
Development only Trouble sleeping ORa 1.42 p = 0.05 and overall prodromal
score ORa 1.03 p = 0.003. Total r squared from final model
0.14 –of limited predictive value. AUCc = 0.59 p<0.59.
N/A
Vigod et al
2015 [15]
Split sample. Model built in one half and validated in the other
half. Four models tested.
Model Derivation
Model 1 –sociodemographic variables only;
Model 2 Model 1 + healthcare utilisation;
Model 3 Model 2 + clinical and administrative admission
information;
Model 4 Model 3 + detailed rating scales.
Log likelihood test to test for improvement in prediction as
each model added. Multivariable logistic regression used.
Model fit assessed using Hosmer-Lemeshow goodness of fit
and discrimination using C statistic
Creation and validation of risk index
Risk index system developed from above. Probability of 30 day
readmission calculated for each score of the risk index. C
statistic calculated for derivation and validation samples
Development and
validation
Association between risk index and outcome ORa 1.11 (95%
CI 1.10–1.12). Probability of 30-day readmission using risk
score from 2% at score of 0 to 49% at a score of 41.
Probability of readmission was within the 95% CI of the
observed probability for all scores in derivation and validation
sample, indicating adequate calibration. Model performance
described as moderate for derivation (C statistic = 0.631) and
validation (C statistic = 0.630).
Validated in
32,750
Key
a Odds Ratio
b Receiver Operating Curve
c Area under the Curve
https://doi.org/10.1371/journal.pone.0183998.t002
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Comparison with previous studies
We are not aware of any previous systematic reviews on prediction models for relapse in psy-
chosis. However, there is one related systematic reviews of risk factors for relapse [22], which
included 29 references and conducted a meta-analysis of 20 predictors. Medication non-
adherence, persistent substance abuse, carers’ critical comments and poor pre-morbid adjust-
ment predicted the risk of relapse by between 2.2 to 4-fold. There are also two systematic
reviews and meta-analyses of randomised controlled trials of second-generation versus first-
generation antipsychotics for reducing relapse in psychosis[23, 24]. Both these reviews found
that second-generation antipsychotics were more effective at reducing relapse. Finally, there is
one systematic review of transitional interventions to reduce early psychiatric readmissions
[7]. Fifteen studies were reviewed and five successful interventions were identified (psychoe-
ducation, structured needs assessments, medication education, transition managers and com-
munication between service providers. It is interesting to notes that neither of the prediction
models reported here included any of these variables.
Strengths and limitations
This systematic review has been conducted using validated and robust methods and the quality
of the studies was evaluated using PROBAST, a new tool that has been developed by methodo-
logical experts in the area of clinical prediction tools and quality assessment [13].
Table 3. Quality assessment of studies included in the systematic review–areas of concern using PROBAST guidelines.
Study Domain 1: Participant selection Domain 2: Predictors Domain 3: Outcomes Domain 4:
Sample size
and
participant
flow
Domain 5:
Analysis
Overall
Judgement
Risk of Bias Applicability Risk of Bias Applicability Risk of Bias Applicability Risk of Bias Risk of Bias
Gaebel
et al
2007
[14]
Low
Justification
Participants not in
similar state of
health but other
predictors such as
psychopathology
were included in to
model to adjust for
this.
Low
Justification
Participants,
setting and
dates match
review
question.
High
Justifications
1/ Assessors
of predictors
not blinded to
outcome
data.
2/ Predictors
were not
defined in
same way for
all
participants.
Low
Justification
Definition,
assessment
and timing of
assessments
match review
question.
High
Justification
Assessors
of outcome
not blinded
to predictor
data.
Low
Justification
Definition,
timing and
determination
match review
question.
High
Justification
Not all
participants
included in
analysis and
not
otherwise
accounted
for.
Low
Justification
Participants,
setting and
dates match
review
question.
High
Justification
At least one
domain at
high risk of
bias
Vigod
et al
2015
[15]
Low
Justification
No concerns
Low
Justification
Participants,
setting and
dates match
review
question.
Low
Justification
No concerns
Low
Justification
Definition,
assessment
and timing of
assessments
match review
question.
.
Low
Justification
No
concerns
Low
Justification
Definition,
timing and
determination
match review
question.
Low
Justification
No concerns
Low
Justification
Split sample a
less rigorous
method of
model
validation
BUT model
was based on
a very large
dataset and
was internally
validated.
Low
Justification
All domains
at low risk of
bias and
internal
validation
concerns
reduced by
use of very
large
dataset.
https://doi.org/10.1371/journal.pone.0183998.t003
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The small number of studies identified in the review, as well as the differences in the mea-
sures of relapse and predictors assessed, meant that it was not appropriate to conduct a formal
meta-analysis. One the most important differences between the studies included our review
was the use of different measures to define a relapse. One study [14] defined relapse as a pre-
defined change in psychometric measures of symptoms, severity and functioning and the
other [15] used admission to hospital. Future studies in this area should move towards a uni-
form measure of relapse to facilitate the pooling of findings. This inconsistency has made it dif-
ficult to compare study findings.
The mean age of the participants in the included studies suggests that the results are more
applicable to older people with chronic psychosis rather than younger people who have been
newly diagnosed and are experiencing their first episode of psychosis.
Clinical implications
Because our systematic review only found two relevant studies which each used a different set
of predictors and one of which was at high risk of bias, it is not possible to recommend either
of these methods of predicting relapse in psychosis. For instance, it is not yet clear whether the
emergence or worsening of prodromal symptoms can accurately predict an impending psy-
chotic relapse. It is possible that a more promising approach may be the use of administrative
data [15]. However, this finding would require replication and external validation before any
conclusion could be reached. The variables used may include a combination of demographic
variables such as age, clinical factors such as diagnosis, measures of severity including harm to
self and others and inability to care for oneself as well as physical illness comorbidities and
data on history of health care service use such as intensity of outpatient and emergency service
use. An important advantage to this approach is that administrative data is readily available
and therefore avoids the extra cost and effort of collecting additional prodromal and psychotic
symptom data. However, it is also important to consider the well-publicised problems with
administrative data, such as unexplained missingness and poor quality, such as recording
errors.
The ability to accurately predict a psychotic relapse would represent an important step
forward in mental health care. It would be particularly useful for mental health system lead-
ership teams to make decisions on the appropriate use of resources, particularly in an envi-
ronment when such resources are in short supply. Those who are at risk of crisis could be
allocated more intensive care with experienced clinicians, whereas those at a lower risk
could be allocated to less intensive or a step-down of care. Resource planning is difficult
and time-consuming without such information. It is also possible that accurate prediction
of which service users were most likely to relapse may allow targeting of an intervention to
reduce the probability of a relapse. This may take the form of increasing medication dose or
psychological intervention. If successful, an intervention which reduces the number of
relapses would also be an important development since there is evidence that a reduction in
the number of psychotic episodes is associated with better outcomes and reduced distress to
the service user and their carer [2, 3, 25, 26]. There would also be the advantage of reduced
treatment costs arising from reduced inpatient admissions because of a relapse. There is
also some evidence [27] that service users could be taught to self-identify relapse indicators
and therefore self-manage prodromal symptoms in order to reduce the probability of
relapse. It has also been suggested [7] that clinicians could perform an unmet needs assess-
ment for service users predicted to be at high risk of relapse and that such assessments can
greatly reduce the risk of psychiatric readmission.
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Future research
It is possible that a prediction model based on administrative data may be a useful approach,
although this needs to be replicated and validated in further datasets. The approach based on
prodromal symptoms may be less useful but to be sure the study should be repeated in a larger
sample with a comparison group and a longer follow-up period. Attention should also be paid
to some of the methodological issues highlighted in this review. For example, it would be pref-
erable to measure relapse and predictors on different occasions and to ensure that the outcome
assessor is blinded to the predictor assessment. Studies which have investigated sensitivity and
specificity of prodromal symptoms may also uncover useful information for further model
development with an investigation of relapses that are predicted by the model but do not
occur.
Supporting information
S1 File. Systematic review protocol.
(DOCX)
S2 File. Search terms.
(DOCX)
S1 Table. PRISMA 2009 checklist.
(DOC)
Acknowledgments
The research is supported by the National Institute for Health Research (NIHR) Collaboration
for Leadership in Applied Health Research and Care West (CLAHRC West) at University Hos-
pitals Bristol NHS Foundation Trust. The views expressed are those of the author(s) and not
necessarily those of the NHS, the NIHR or the Department of Health.
Author Contributions
Conceptualization: Sarah Sullivan, Kate Northstone, Caroline Gadd, Julian Walker, Ruta
Margelyte, Alison Richards, Penny Whiting.
References
1. Robinson D, Woerner MG, Alvir JM, Bilder R, Goldman R, Geisler S, et al. Predictors of relapse follow-
ing response from a first episode of schizophrenia or schizoaffective disorder. Archives of general psy-
chiatry. 1999; 56(3):241–7. PMID: 10078501.
2. Weiden PJ, Olfson M. Cost of Relapse in Schizophrenia. Schizophrenia Bulletin. 1995; 21(3):419–29.
PMID: 7481573
3. Wiersma D, Nienhuis FJ, Slooff CJ, Giel R. Natural course of Schizophrenic disorders: A 15-year fol-
lowup of a Dutch incidence cohort. Schizophrenia Bulletin. 1998; 24(1):75–85. PMID: 9502547
4. Rooke O, Birchwood M. Loss, humiliation and entrapment as appraisals of schizophrenic illness: A pro-
spective study of depressed and non-depressed patients. Br J Clin Psychol. 1998; 37:259–68. PMID:
9874588
5. Schizophrenia Commission. The Abandoned Illness. 2012.
6. Hong JY, Windmeijer F, Novick D, Haro JM, Brown J. The cost of relapse in patients with schizophrenia
in the European SOHO (Schizophrenia Outpatient Health Outcomes) study. Progress in Neuro-Psycho-
pharmacology & Biological Psychiatry. 2009; 33(5):835–41. doi: 10.1016/j.pnpbp.2009.03.034. PMID:
19351551
Models to predict relapse in psychosis: A systematic review
PLOS ONE | https://doi.org/10.1371/journal.pone.0183998 September 21, 2017 11 / 12
7. Vigod SN, Kurdyak PA, Dennis CL, Leszcz T, Taylor VH, Blumberger DM, et al. Transitional interven-
tions to reduce early psychiatric readmissions in adults: systematic review. British Journal of Psychiatry.
2013; 202(3):187–94. doi: 10.1192/bjp.bp.112.115030. PMID: 23457182
8. Centre for Reviews and Dissemination. Systematic Reviews: CRD’s guidance for undertaking reviews
in health care. York: University of York, 2009.
9. Collaboration. C. Cochrane Methods Prognosis. Trusted evidence. Informed decisions. Better health.
2016. Available from: http://methods.cochrane.org/prognosis.
10. Higgins JPT, Green S, editors. Cochrane handbook for systematic reviews of interventions [Internet].
Version 5.1.0 [updated March 2011]: The Cochrane Collaboration; 2011 [accessed 23.3.11].
11. Geersing G- J, Bouwmeester W, Zuithoff P, Spijker R, Leeflang M, Moons KGM, et al. Search filters for
finding prognostic and diagnostic prediction studies in Medline to enhance systematic reviews. PLoS
One. 2012; 7(2):e32844. https://doi.org/10.1371/journal.pone.0032844 PMID: 22393453.
12. Moons KG, de Groot JAH, Bouwmeester W, Vergouwe Y, Mallett S, Altman DG, et al. Critical appraisal
and data extraction for systematic reviews of predictgion modelling studies: The CHARMS Checklist.
PLoS One. 2014; 11(10).
13. Wolff R, Whiting P, Westwood M, Kleijnen J, Mallet S, Riley R, et al. PROBAST 2015. Available from:
http://www.systematic-reviews.com/.
14. Gaebel W, Riesbeck M. Revisiting the relapse predictive validity of prodromal symptoms in schizophre-
nia. Schizophrenia Research. 2007; 95(1–3):19–29. https://doi.org/10.1016/j.schres.2007.06.016
PMID: 17630253.
15. Vigod SN, Kurdyak PA, Seitz D, Herrmann N, Fung K, Lin E, et al. READMIT: a clinical risk index to pre-
dict 30-day readmission after discharge from acute psychiatric units. Journal of Psychiatric Research.
2015; 61:205–13. http://dx.doi.org/10.1016/j.jpsychires.2014.12.003. https://doi.org/10.1016/j.
jpsychires.2014.12.003 PMID: 25537450.
16. Dawson M. Preventing relapse amongst schizophrenia patients: University of Southern California;
2013. Available from: https://news.usc.edu/56486/preventing-relapse-among-schizophrenia-patients/.
17. Dobson R, MacCabe J. Sleep sensors to prevent relapse in schizophrenia 2014. Available from: http://
www.kcl.ac.uk/ioppn/news/records/2014/October/Sleep-sensors-to-detect-relapse-in-schizophrenia.
aspx.
18. Eisner E, Drake R, Barrowclough C. Assessing early signs of relapse in psychosis: Review and future
directions. Clinical Psychology Review. 2013; 33(5):637–53. doi: 10.1016/j.cpr.2013.04.001. PMID:
23628908
19. Ben-Zeev R. Smart phone app keeps watch over schizophrenia patients 2014. Available from: http://
spectrum.ieee.org/biomedical/diagnostics/smartphone-app-keeps-watch-over-schizophrenic-patients.
20. Davis UC. App aims to prevent relapse in psychosis patients. 2015.
21. Lahti AC. Prediction of relapse in schizophrenia/schizoaffective disorder with smartphones and on-body
sensors 2014. Available from: https://www.clinicaltrials.gov/ct2/show/NCT02224430.
22. Alvarez-Jimenez M, Priede A, Hetrick SE, Bendall S, Killackey E, Parker AG, et al. Risk factors for
relapse following treatment for first episode psychosis: A systematic review and meta-analysis of longi-
tudinal studies. Schizophrenia Research. 2012; 139(1–3):116–28. doi: 10.1016/j.schres.2012.05.007.
PMID: 22658527
23. Kishimoto T, Agarwal V, Kishi T, Leucht S, Kane JM, Correll CU. Relapse prevention in schizophrenia:
a systematic review and meta-analysis of second-generation antipsychotics versus first-generation anti-
psychotics. Molecular Psychiatry. 2013; 18(1):53–66. doi: http://dx.doi.org/10.1038/mp.2011.143.
https://doi.org/10.1038/mp.2011.143 PMID: 22124274; PubMed Central PMCID: PMCNIHMS329515
PMC3320691.
24. Leucht S, Barnes TR, Kissling W, Engel RR, Correll C, Kane JM. Relapse prevention in schizophrenia
with new-generation antipsychotics: a systematic review and exploratory meta-analysis of randomized,
controlled trials. American Journal of Psychiatry. 2003; 160(7):1209–22. https://doi.org/10.1176/appi.
ajp.160.7.1209 PMID: 12832232.
25. Wiersma D, Wanderling J, Dragomirecka E, Ganev K, Harrison G, an der Heiden W, et al. Social disabil-
ity in schizophrenia: Its development and prediction over 15 years in incidence cohorts in six European
centres. European Psychiatry. 2000; 15:292s-s. doi: 10.1016/S0924-9338(00)94276-7.
ISI:000165731700255.
26. Buchanan RW, Kreyenbuhl J, Kelly DL, Noel JM, Boggs DL, Fischer BA, et al. The 2009 Schizophrenia
PORT Psychopharmacological Treatment Recommendations and Summary Statements. Schizophre-
nia Bulletin. 2010; 36(1):71–93. doi: 10.1093/schbul/sbp116. PMID: 19955390
27. Tarrier N. Management and modification of residual psychotic symptoms. In: Birchwood M, Tarrier N,
editors. Innovations in the psychological management of schizophrenia. Chichester: Wiley; 1991.
Models to predict relapse in psychosis: A systematic review
PLOS ONE | https://doi.org/10.1371/journal.pone.0183998 September 21, 2017 12 / 12
